Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Polycythaemia and neuroblastoma.

J K Murphy1, K M Hunt

  • 1Department of Pathology, Bradford Royal Infirmary, West Yorkshire.

Irish Journal of Medical Science
|April 1, 1991
PubMed
Summary

Radioactive phosphorus (P32) therapy for polycythaemia vera may increase cancer risk. This case highlights a potential link between P32 treatment and the development of malignant neuroblastoma.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Methodological approaches to situational analysis in global mental health: a scoping review.

Global mental health (Cambridge, England)·2019
Same author

Chronic B-Cell Malignancies in Patients with Lymphocytosis.

Leukemia & lymphoma·2016
Same author

Bovine hepatic and adipose retinol-binding protein gene expression and relationship with tumor necrosis factor-α.

Journal of dairy science·2012
Same author

Human milk oligosaccharides promote the growth of staphylococci.

Applied and environmental microbiology·2012
Same author

Surgical presentation of primary extranodal gastrointestinal non-Hodgkin's lymphoma.

West African journal of medicine·2010
Same author

Proliferative Hairy Cell Leukaemia (HCL-v) Resistant to Alpha-Interferon: Clinical, Diagnostic and In-Vitro Cellular Characteristics.

Leukemia & lymphoma·2010

Area of Science:

  • Hematology
  • Oncology
  • Nuclear Medicine

Background:

  • Polycythaemia vera is a myeloproliferative neoplasm.
  • Treatment options include venesection and radioactive phosphorus (P32).
  • P32 therapy is associated with risks of secondary malignancies like acute leukaemia and carcinoma.

Observation:

  • A patient with primary proliferative polycythaemia was treated with venesection and P32.
  • The patient developed malignant neuroblastoma during follow-up.
  • This case presents a rare complication of P32 therapy.

Findings:

  • The development of malignant neuroblastoma following P32 treatment for polycythaemia vera.
  • This finding expands the known spectrum of P32-associated secondary cancers.
  • Highlights the importance of long-term surveillance in patients treated with P32.

Implications:

  • Suggests a potential oncogenic effect of P32 beyond leukaemia and carcinoma.
  • Underscores the need for careful risk-benefit assessment when considering P32 therapy.
  • Emphasizes the importance of continued research into the long-term effects of P32 treatment.

Related Experiment Videos